$141.86
00.00%
Last update: 4:05 PM
15 minutes delayed
Comments
Loading...
DaVita
DVANYSE
DaVita (NYSE:DVA) Stock, Analyst Ratings, Price Targets, Forecasts
DaVita Inc has a consensus price target of $118.6 based on the ratings of 10 analysts. The high is $150 issued by Truist Securities on May 15, 2024. The low is $90 issued by Cowen & Co. on February 23, 2023. The 3 most-recent analyst ratings were released by Truist Securities, Barclays, and Barclays on May 15, 2024, May 6, 2024, and March 6, 2024, respectively. With an average price target of $144.33 between Truist Securities, Barclays, and Barclays, there's an implied 0.97% upside for DaVita Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Truist Securities
Barclays
Barclays
UBS
Bernstein
1calculated from analyst ratings
Analyst Ratings for DaVita
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 05/15/2024 | Buy Now | 4.93% | Truist Securities | David Macdonald | $135 → $150 | Maintains | Hold | Get Alert |
| 05/06/2024 | Buy Now | 4.93% | Barclays | Andrew Mok | $133 → $150 | Maintains | Equal-Weight | Get Alert |
| 03/06/2024 | Buy Now | -6.96% | Barclays | Sarah James | → $133 | Initiates | → Equal-Weight | Get Alert |
| 02/20/2024 | Buy Now | -5.56% | Truist Securities | David Macdonald | $130 → $135 | Maintains | Hold | Get Alert |
| 02/15/2024 | Buy Now | 1.43% | UBS | Andrew Mok | $134 → $145 | Maintains | Buy | Get Alert |
| 02/14/2024 | Buy Now | -6.26% | UBS | Andrew Mok | $113 → $134 | Maintains | Buy | Get Alert |
| 02/14/2024 | Buy Now | -9.06% | Truist Securities | David Macdonald | $120 → $130 | Maintains | Hold | Get Alert |
| 11/17/2023 | Buy Now | -20.95% | UBS | Andrew Mok | $142 → $113 | Maintains | Buy | Get Alert |
| 10/11/2023 | Buy Now | -27.25% | Truist Securities | David Macdonald | $115 → $104 | Maintains | Hold | Get Alert |
| 08/07/2023 | Buy Now | -0.66% | UBS | Andrew Mok | $100 → $142 | Upgrade | Neutral → Buy | Get Alert |
| 07/13/2023 | Buy Now | -19.55% | Truist Securities | David Macdonald | $100 → $115 | Maintains | Hold | Get Alert |
| 05/15/2023 | Buy Now | -30.05% | Bernstein | Lisa Bedell Clive | $88 → $100 | Maintains | Market Perform | Get Alert |
| 05/09/2023 | Buy Now | -20.95% | Deutsche Bank | Pito Chickering | $85 → $113 | Maintains | Hold | Get Alert |
| 05/09/2023 | Buy Now | -30.05% | Truist Securities | David Macdonald | $90 → $100 | Maintains | Hold | Get Alert |
| 05/09/2023 | Buy Now | -31.44% | TD Cowen | Gary Taylor | $90 → $98 | Maintains | Market Perform | Get Alert |
| 05/09/2023 | Buy Now | -32.84% | B of A Securities | Kevin Fischbeck | $86 → $96 | Maintains | Underperform | Get Alert |
| 03/07/2023 | Buy Now | — | Bernstein | Lisa Bedell Clive | — | Reinstates | → Market Perform | Get Alert |
| 02/23/2023 | Buy Now | -37.04% | Cowen & Co. | Gary Taylor | $76 → $90 | Maintains | Outperform | Get Alert |
| 02/23/2023 | Buy Now | -37.04% | Truist Securities | David Macdonald | $84 → $90 | Maintains | Hold | Get Alert |
| 10/31/2022 | Buy Now | -47.53% | Truist Securities | David Macdonald | $90 → $75 | Maintains | Hold | Get Alert |
| 10/31/2022 | Buy Now | -43.34% | Barclays | Sarah James | $103 → $81 | Maintains | Equal-Weight | Get Alert |
| 10/31/2022 | Buy Now | -48.23% | UBS | Andrew Mok | $117 → $74 | Downgrade | Buy → Neutral | Get Alert |
| 08/19/2022 | Buy Now | -18.15% | UBS | Andrew Mok | $106 → $117 | Upgrade | Neutral → Buy | Get Alert |
| 08/04/2022 | Buy Now | -27.95% | Barclays | Sarah James | $128 → $103 | Maintains | Equal-Weight | Get Alert |
| 08/02/2022 | Buy Now | -32.14% | Deutsche Bank | Pito Chickering | $150 → $97 | Maintains | Buy | Get Alert |
| 06/22/2022 | Buy Now | -37.04% | Truist Securities | David Macdonald | $110 → $90 | Maintains | Hold | Get Alert |
| 01/05/2022 | Buy Now | -12.56% | Truist Securities | David Macdonald | $114 → $125 | Maintains | Hold | Get Alert |
| 10/29/2021 | Buy Now | -22.35% | RBC Capital | Frank Morgan | — | Maintains | Sector Perform | Get Alert |
| 10/13/2021 | Buy Now | -12.56% | Truist Securities | David Macdonald | — | Maintains | Hold | Get Alert |
| 09/10/2021 | Buy Now | 1.43% | Cowen & Co. | Gary Taylor | — | Initiates | → Market Perform | Get Alert |
| 08/12/2021 | Buy Now | 2.13% | Barclays | Sarah James | — | Downgrade | Overweight → Equal-Weight | Get Alert |
FAQ
What is the target price for DaVita (DVA) stock?
The latest price target for DaVita (NYSE:DVA) was reported by Truist Securities on May 15, 2024. The analyst firm set a price target for $150.00 expecting DVA to rise to within 12 months (a possible 5.74% upside). 10 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for DaVita (DVA)?
The latest analyst rating for DaVita (NYSE:DVA) was provided by Truist Securities, and DaVita maintained their hold rating.
When was the last upgrade for DaVita (DVA)?
The last upgrade for DaVita Inc happened on August 7, 2023 when UBS raised their price target to $142. UBS previously had a neutral for DaVita Inc.
When was the last downgrade for DaVita (DVA)?
The last downgrade for DaVita Inc happened on October 31, 2022 when UBS changed their price target from $117 to $74 for DaVita Inc.
When is the next analyst rating going to be posted or updated for DaVita (DVA)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of DaVita, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for DaVita was filed on May 15, 2024 so you should expect the next rating to be made available sometime around May 15, 2025.
Is the Analyst Rating DaVita (DVA) correct?
While ratings are subjective and will change, the latest DaVita (DVA) rating was a maintained with a price target of $135.00 to $150.00. The current price DaVita (DVA) is trading at is $141.86, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.